Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Penile Neoplasms 1Melanoma 1Liver Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Anus Neoplasms 1

Interventions

fludarabine 5Cyclophosphamide 5aldesleukin 4fludarabine phosphate 2entinostat 2aflibercept 2Radiotherapy 2Adoptive Transfer 2rocakinogene sifuplasmid 1ripretinib 1pembrolizumab 1oncogene protein E7, Human papillomavirus type 16 1durvalumab 1bintrafusp alfa protein, human 1Vorinostat 1Vaccines, Synthetic 1VGX-3100 1Ritonavir 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1MEDI0457 1Isotretinoin 1Interleukin-2 1Interferon-alpha 1Indinavir 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Penile Neoplasms × Ganciclovir × Gastrointestinal × Clear all
NCT05578820 2024-07-01

Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Gene Surgery LLC

Phase 1 Completed
21 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Melanoma, Penile Neoplasms, Sarcoma, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡